Topic: SNF-Antipsychotic-Use

Antipsychotic Drugs in Nursing Homes

The misuse of antipsychotic drugs as chemical restraints is one of the most common and longstanding, but preventable, practices causing serious harm to nursing home residents today. We thank the Senate Special Committee on Aging for holding today’s hearing.

Elder Abuse in Nursing Facilities: The Over-Administration of Antipsychotic Drugs to Nursing Home Residents

The Administration on Aging defines a subcategory of elder abuse – “physical abuse” – as “inflicting physical pain or injury on a senior, e.g. slapping, bruising, or restraining by physical or chemical means.” Administering antipsychotic drugs to more than a quarter of a million nursing home residents meets the definition of elder abuse and, left unanswered, is a national scandal.

Antipsychotic Drugs and Nursing Home Residents: What Do the Different Numbers Mean?

The CMS Partnership and the GAO reported different numbers of nursing home residents receiving antipsychotic drugs.  Some of the differences appear to reflect the different databases and assumptions underlying CMS’s and the GAO’s work.  This Alert explains these differences and advantages and disadvantages of each approach. 

Has CMS’s Partnership with the Nursing Home Industry Really Reduced the Inappropriate Use of Antipsychotic Drugs by Nursing Home Residents as Much as CMS Claims? No.

Has CMS’s Partnership with the Nursing Home Industry Really Reduced the Inappropriate Use of Antipsychotic Drugs by Nursing Home Residents as Much as CMS Claims? No.

CMA Report: Inappropriate Use of Antipsychotic Drugs in Nursing Homes, Part Three – Recommendations to Improve the Citing of Deficiencies

CMA Report: Inappropriate Use of Antipsychotic Drugs in Nursing Homes, Part Three – Recommendations to Improve the Citing of Deficiencies

CMA Report on Inappropriate Use of Antipsychotic Drugs in Nursing Homes – Part Two: What the Surveyors Say

CMA Report on Inappropriate Use of Antipsychotic Drugs in Nursing Homes – Part Two: What the Surveyors Say

Misuse of Antipsychotic Drugs in Nursing Homes: Are We Making Any Progress?

Inappropriate use of antipsychotic drugs by nursing facilities remains a significant problem.

$2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia

The Department of Justice's $2.2 billion settlement with Johnson & Johnson over allegations that it illegally promoted Risperdal to treat symptoms of dementia sends a new warning to the pharmaceutical and long-term care industries that antipsychotic drugs are inappropriate and potentially dangerous when prescribed for the elderly.

$2.2 Billion Johnson & Johnson Settlement Sends New Warning: Antipsychotic Drugs Should Not Be Used to Treat Dementia

The Department of Justice's $2.2 billion settlement with Johnson & Johnson over allegations that it illegally promoted Risperdal to treat symptoms of dementia sends a new warning to the pharmaceutical and long-term care industries that antipsychotic drugs are inappropriate and potentially dangerous when prescribed for the elderly.

Misuse of Antipsychotic Drugs in Nursing Homes: Are We Making Any Progress?

The recent settlement of criminal and civil charges against Johnson & Johnson for off-label marketing of Risperdal for nursing home residents once again brings the issue of antipsychotic drugs and nursing homes to public attention. A group of residents' advocates working to reduce the inappropriate use of antipsychotic drugs in nursing facilities recently issued a joint Statement about the settlement.[1] This Alert discusses the Johnson & Johnson settlement and three additional developments th

Examining Inappropriate Use of Antipsychotic Drugs, Part Three: Recommendations

This Report looks at Survey and Certification deficiency citations for antipsychotic drug use in skilled nursing facilities (SNFs) and nursing facilities (NFs). This part presents recommendations for specific and important ways to improve the citing of antipsychotic drug deficiencies, and consequently, to improve the health, safety, welfare, and rights of nursing home residents throughout the United States.

Examining Inappropriate Use of Antipsychotic Drugs, Part Two: How Surveyors Describe How, When, and Why They Cite Antipsychotic Drug Deficiencies

Examining Inappropriate Use of Antipsychotic Drugs, a Report in three Parts, looks at antipsychotic drug use in skilled nursing facilities (SNFs) and nursing facilities (NFs). In this Part, it reports the perspectives of state Surveyors on the survey process, in general, and the citing of antipsychotic drug deficiencies, in particular

Page 1 of 2 1 2